Techniques such as positron emission tomography (PET) and magnetic resonance imaging (MRI) have been adapted with novel radiotracers and contrast agents targeting immune markers like PD-1/PD-L1, activated T cells, and macrophages within the tumor microenvironment. This evidence concerns the gene CD274 and neoplasm.